Notably, patients prescribed GLP‐1RAs were more likely to have obesity, to be identified as White race, and to have no documented diabetes recorded in their EHR; patients prescribed long‐acting insulin were more likely to be identified as Black race. The gene discussed is INS; the disease is obesity disorder.